Skip to content

Study of the Effectiveness of Specific Training of Health Professionals on Adherence in Bipolar Disorder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02904083
Acronym
CONCORDE
Enrollment
300
Registered
2016-09-16
Start date
2017-06-30
Completion date
2020-06-30
Last updated
2016-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorders

Brief summary

Bipolar disorders are common psychiatric disorders characterized by severe and recurrent symptomatic periods (Major Depressive Episode, mania, hypomania) and interictal periods characterized by persistent residual symptoms, impaired functioning and quality of life. In addition, the prognosis of bipolar disorder is aggravated by an increased risk of suicide and a high frequency of somatic comorbidities. Poor adherence is one of the major factors influencing the course of the disorder and one of the causes of ineffective treatments. Considering that between 20 and 60% of patients with bipolar disorder have problems with adherence. Adherence is modulated by a number of socio-demographic, clinical and neuropsychological factors. It is also modulated by the knowledge, beliefs and In addition, studies have shown that the reasons attributed to poor adherence are different depending on whether questioning patients or healthcare professionals. This fault diagnosis, assessment of the causes and fit into the reasons associated with poor adherence is an aggravating factor of the problem. However, this factor seems modifiable by better training of professionals. A team from Newcastle University in England has developed a training program for all health professionals to improve the diagnosis and understanding of compliance issues in bipolar patients and provide simple tools to fight against patients with this problem. The investigators assume that this training will improve medication adherence among outpatients by trained professionals.

Interventions

BEHAVIORALself assessment of adherence

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suffering from bipolar disorder type 1, type 2 or unspecified according to the DSM IV * Do not presenting mood episode as defined in DSM IV * With at least one medication prescribed mood stabilizer goal, whatever its observance

Exclusion criteria

* Patients full-time hospitalized at the time of inclusion

Design outcomes

Primary

MeasureTime frame
Difference of score of Medication Adherence Rating Scale (MARS) before and after the training of the professionals6 months

Countries

France

Contacts

Primary ContactRaoul Belzeaux, MD
raoul.belzeaux@ap-hm.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026